Metabolism of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone(M73101), A New anti-inflammatory agent. I. Identification of the metabolites in rabbit and their pharmacological studies.

Identification of cannabichromene metabolites by mass spectrometry: identification of eight new dihydroxy metabolites in the rabbit.

Metabolism of papaverine. I. Identification of metabolites in rat bile.

Studies on antiinflammatory agents. I. Synthesis and pharmacological properties of 2'-phenoxymethanesulfonanilide derivatives.

Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.

Isolation, identification and pharmacological studies on three toxic metabolites from a mushroom, Hebeloma spoliatum.

[Synthesis of metabolites of mosapramine. II. Synthesis of phenolic metabolites of mosapramine and their pharmacological activities].

Pharmacological studies on pueraria root. I. Fractional extraction of pueraria root and identification of its pharmacological effects.

Mass spectrometric identification of urinary and plasma metabolites of 2-(6'-carboxyhexyl)-3-n-hexylcyclohexylamine, a new antiaggregating agent.

Cyclobenzaprine: a new look at an old pharmacological agent.

The effect of a putative anti-atherosclerotic agent (S 1204) on lipid metabolism in rabbit aorta.

New pharmacological studies with pentoxifylline.

Metabolism of budralazine, a new antihypertensive agent, III.

Pharmacological studies on Daucus carota part I.

Metabolism of minoxidil, a new hypotensive agent I: absorption, distribution, and excretion following administration to rats, dogs, and monkeys.

Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry.

New synthesis of 1,4,2-dioxazoles and their pharmacological properties.

Antiinflammatory reactivity of copper(I)-thionein.

Determination of the psychoactive drugs carbamazepine and diazepam in hospital effluent and identification of their metabolites.

Studies on the metabolism of meptazinol, a new analgesic drug.

[Pharmacological and clinical profile of ipragliflozin (Suglat®): a new therapeutic agent for type 2 diabetes].

Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers.

Recent Advances in Mass Spectrometry for the Identification of Neuro-chemicals and their Metabolites in Biofluids.

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

Mode of relaxing action of FK336, a new antianginal agent, in rabbit aorta.

Suggest Documents

Identification of cannabichromene metabolites by mass spectrometry: identification of eight new dihydroxy metabolites in the rabbit.

Metabolism of papaverine. I. Identification of metabolites in rat bile.

Studies on antiinflammatory agents. I. Synthesis and pharmacological properties of 2'-phenoxymethanesulfonanilide derivatives.

Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.

Isolation, identification and pharmacological studies on three toxic metabolites from a mushroom, Hebeloma spoliatum.

[Synthesis of metabolites of mosapramine. II. Synthesis of phenolic metabolites of mosapramine and their pharmacological activities].

Pharmacological studies on pueraria root. I. Fractional extraction of pueraria root and identification of its pharmacological effects.

Mass spectrometric identification of urinary and plasma metabolites of 2-(6'-carboxyhexyl)-3-n-hexylcyclohexylamine, a new antiaggregating agent.

Cyclobenzaprine: a new look at an old pharmacological agent.

The effect of a putative anti-atherosclerotic agent (S 1204) on lipid metabolism in rabbit aorta.

New pharmacological studies with pentoxifylline.

Metabolism of budralazine, a new antihypertensive agent, III.

Pharmacological studies on Daucus carota part I.

Metabolism of minoxidil, a new hypotensive agent I: absorption, distribution, and excretion following administration to rats, dogs, and monkeys.

Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry.

New synthesis of 1,4,2-dioxazoles and their pharmacological properties.

Antiinflammatory reactivity of copper(I)-thionein.

Determination of the psychoactive drugs carbamazepine and diazepam in hospital effluent and identification of their metabolites.

Studies on the metabolism of meptazinol, a new analgesic drug.

[Pharmacological and clinical profile of ipragliflozin (Suglat®): a new therapeutic agent for type 2 diabetes].

Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers.

Recent Advances in Mass Spectrometry for the Identification of Neuro-chemicals and their Metabolites in Biofluids.

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

Mode of relaxing action of FK336, a new antianginal agent, in rabbit aorta.

Metabolism of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone(M73101), A New anti-inflammatory agent. I. Identification of the metabolites in rabbit and their pharmacological studies.

Recommend Documents

Follow Us